Implication of the EZH2 methyltransferase and its upstream regulator H19 in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a progressive condition characterized by the chronic elevation of pulmonary artery (PA) pressure leading to failure of the heart. In spite of recent advances in approved therapies, PAH remains a serious disease with significant mortality.